TipRanks
BioRegenx (BRGX)
OTHER OTC:BRGX
US Market
BRGX
BioRegenx
RESEARCH TOOLSreports

BioRegenx (BRGX) Income Statement

24 Followers

BioRegenx Income Statement

Last quarter (Q1 2026), BioRegenx's total revenue was $426.18K, a decrease of -17.27% from the same quarter last year. In Q1, BioRegenx's net income was $-26.41K. See BioRegenx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.85M$ 2.34M$ 22.24K$ 42.16K$ 198.58K
Gross Profit
$ 1.50M$ 1.66M$ 16.31K$ 36.23K$ 198.03K
Operating Expenses
$ 2.02M$ 23.74M$ 125.97K$ 114.53K$ 363.15K
Depreciation and Amortization
$ 75.08K$ 2.22M$ 5.93K$ 5.93K$ 4.45K
EBITDA
$ -443.92K$ -22.76M$ -557.07K$ -72.38K$ -161.00K
Operating Income
$ -518.99K$ -22.76M$ -110.00K$ -78.31K$ -165.00K
Other Income/Expenses
$ -1.02M$ -290.66K$ -462.00K$ 0.00$ 68.25K
Pretax Income
$ -1.54M$ -23.05M$ -571.00K$ -78.31K$ -96.87K
Net Income
$ -1.54M$ -23.05M$ -571.00K$ -78.31K$ -96.87K
Per Share Metrics
Basic EPS
$ >-0.01$ -0.02$ >-0.01$ >-0.01$ >-0.01
Diluted EPS
$ >-0.01$ -0.02$ >-0.01$ >-0.01$ >-0.01
Weighted Average Shares Outstanding
 959.71M 939.51M 276.37M 269.75M 269.75M
Weighted Average Shares Outstanding (Diluted)
 959.71M 939.51M 276.37M 269.75M 269.75M
Currency in USD

BioRegenx Earnings and Revenue History